Characteristics of 52 patients who underwent second-line therapy
| . | SAA . | VSAA . |
|---|---|---|
| Patients | 21 | 31 |
| Sex, M/F | 14/7 | 14/17 |
| Median age, y (range) | 9 (2-17) | 8 (0-17) |
| Cause of AA | ||
| Idiopathic | 17 | 29 |
| Hepatitis | 4 | 2 |
| Severity of disease | ||
| SAA | 7 | 21 |
| VSAA | 14 | 10 |
| Median months from diagnosis to second-line therapy (range) | 7 (5-25) | 8 (5-20) |
| . | SAA . | VSAA . |
|---|---|---|
| Patients | 21 | 31 |
| Sex, M/F | 14/7 | 14/17 |
| Median age, y (range) | 9 (2-17) | 8 (0-17) |
| Cause of AA | ||
| Idiopathic | 17 | 29 |
| Hepatitis | 4 | 2 |
| Severity of disease | ||
| SAA | 7 | 21 |
| VSAA | 14 | 10 |
| Median months from diagnosis to second-line therapy (range) | 7 (5-25) | 8 (5-20) |
Data are numbers except where indicated.